Thursday, March 23, 2023 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

SAN DIEGO - Insiders at Santarus will profit unfairly from their proposed sale to Salix Pharmaceuticals for $32 a share or $2.6 billion, shareholders claim in Federal Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.